Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Mirror Therapy Versus Action Observation Therapy on Upper Limb Motor Function, Functional Independence, and Quality Oflife Among Chronic Stroke Patients

6 juin 2026 mis à jour par: University of Lahore
This randomized controlled trial aims to compare the effects of Mirror Therapy (MT) and Action Observation Therapy (AOT) on upper limb motor function, functional independence, and health-related quality of life in individuals with chronic stroke. Stroke-related upper limb impairment remains a major cause of long-term disability and reduced independence. Both MT and AOT are neurocognitive rehabilitation approaches based on activation of the mirror neuron system and promotion of neuroplasticity. Eligible participants with chronic stroke will be randomly allocated to either a Mirror Therapy group or an Action Observation Therapy group and will receive supervised interventions in addition to standard physiotherapy. Outcomes will be assessed using the Motor Evaluation Scale for Upper Extremity in Stroke Patients (MESUPES), Fugl-Meyer Assessment for Upper Extremity (FMA-UE), and Short Form-36 Health Survey (SF-36). The study seeks to determine the comparative effectiveness of these interventions for improving upper limb function, functional independence, and quality of life among chronic stroke survivors.

Aperçu de l'étude

Description détaillée

Stroke is a leading cause of long-term disability worldwide and frequently results in persistent upper limb impairments that limit functional independence and participation in daily activities. Despite advances in rehabilitation, many stroke survivors continue to experience deficits in motor control, coordination, dexterity, and upper extremity function, particularly during the chronic phase of recovery. Therefore, identifying effective rehabilitation strategies that promote neuroplasticity and enhance motor recovery remains a priority in stroke rehabilitation.

Mirror Therapy (MT) and Action Observation Therapy (AOT) are neurocognitive rehabilitation interventions that have gained increasing attention because of their potential to facilitate motor recovery through activation of the mirror neuron system. Mirror Therapy involves observation of the reflection of movements performed by the unaffected limb, creating the visual illusion that the affected limb is moving normally. This visual feedback is believed to stimulate motor cortical areas and promote motor relearning. Action Observation Therapy involves observation of goal-directed motor tasks performed by another individual, followed by active imitation of the observed movements. Through observation and execution of actions, AOT is intended to enhance motor planning, motor learning, and cortical reorganization.

Although both interventions have demonstrated potential benefits in stroke rehabilitation, limited evidence exists directly comparing their effectiveness for improving upper limb function, functional independence, and quality of life among individuals with chronic stroke. This study has been designed to address this gap by evaluating and comparing the clinical effects of MT and AOT within a randomized controlled trial framework.

The study will be conducted at Goshe Shifa Hospital, Lahore, Pakistan. Participants diagnosed with chronic stroke (six months or more post-stroke), aged 45-75 years, with mild-to-moderate upper limb motor impairment, will be screened for eligibility. Eligible participants will be randomly assigned to one of two intervention groups using a computer-generated randomization sequence with allocation concealment through sealed opaque envelopes.

Participants allocated to the Mirror Therapy group will receive a structured upper limb rehabilitation program utilizing mirror-induced visual feedback. Sessions will include simple upper limb movements, functional activities, and task-specific training performed while observing the mirror reflection of the unaffected limb. Participants allocated to the Action Observation Therapy group will observe videos demonstrating goal-directed upper limb activities and subsequently practice the observed tasks under physiotherapy supervision.

Both interventions will be delivered for six weeks, five sessions per week, with each session lasting approximately 45 minutes. Outcome assessments will be performed at baseline and after completion of the intervention period by assessors blinded to group allocation.

The primary outcomes of interest include upper limb motor function, functional independence, and health-related quality of life. These outcomes will be measured using the Motor Evaluation Scale for Upper Extremity in Stroke Patients (MESUPES), Fugl-Meyer Assessment for Upper Extremity (FMA-UE), and Short Form-36 Health Survey (SF-36), respectively.

The study is expected to contribute evidence regarding the comparative effectiveness of two widely used neurorehabilitation approaches and may assist clinicians in selecting appropriate interventions for upper limb rehabilitation in individuals with chronic stroke.

Type d'étude

Interventionnel

Inscription (Réel)

76

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

      • Lahore, Pakistan, 54590
        • The University of Lahore Teaching Hospital

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

  • Adulte
  • Adulte plus âgé

Accepte les volontaires sains

Non

La description

Inclusion Criteria:

  • Individuals diagnosed with chronic stroke (≥6 months post-stroke).
  • Patients with stroke affecting either the left or right upper limb will be included.
  • Mild-to-moderate upper limb motor impairment (Fugl-Meyer Upper Extremity Score between 19-55).
  • Ability to follow verbal and visual instructions.
  • Medically stable with no active comorbidities affecting rehabilitation (Tang et al., 2024).

Exclusion Criteria:

  • Severe cognitive or communication impairments prevent task understanding.
  • Presence of severe upper limb spasticity or contractures.
  • History of severe visual or perceptual deficits (e.g., neglect, hemianopia).
  • Uncontrolled epilepsy or active psychiatric disorders.
  • Participation in other upper limb rehabilitation programs during the study period.

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Traitement
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Seul

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: Mirror Therapy Group
Participants assigned to this group will receive Mirror Therapy in addition to standard physiotherapy. A mirror will be positioned in the midline so that movements of the unaffected upper limb are reflected, creating the visual illusion that the affected limb is moving normally. Treatment sessions will last 45 minutes, five days per week for six weeks. The intervention will include simple joint movements, functional upper limb activities, and task-specific training designed to promote motor recovery, functional independence, and neuroplasticity.
Participants assigned to the Mirror Therapy intervention will receive supervised upper limb rehabilitation using mirror-induced visual feedback. A mirror will be positioned in the participant's midline, allowing observation of the reflection of the unaffected upper limb while the affected limb remains hidden. Sessions will include simple joint movements, functional tasks, and task-specific activities designed to promote motor relearning and cortical reorganization. Treatment will be delivered for 45 minutes per session, five days per week, for six weeks, alongside standard physiotherapy.
Expérimental: Action Observation Therapy Group
Participants assigned to this group will receive Action Observation Therapy in addition to standard physiotherapy. Participants will observe videos demonstrating goal-directed upper limb activities and subsequently imitate the observed movements under physiotherapist supervision. Treatment sessions will last 45 minutes, five days per week for six weeks. The intervention will include observation, guided imitation, and repetitive practice of functional tasks aimed at improving motor planning, motor execution, upper limb function, and functional independence.
Participants assigned to the Action Observation Therapy intervention will observe videos demonstrating goal-directed upper limb activities and subsequently practice the observed movements under physiotherapist supervision. The intervention consists of an observation phase, guided imitation, and repetitive task practice to facilitate motor learning and neuroplasticity. Treatment sessions will last 45 minutes and will be conducted five days per week for six weeks in addition to standard physiotherapy.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Upper Limb Motor Function
Délai: Baseline and 6 weeks (end of intervention)
Upper limb motor function will be assessed using the Motor Evaluation Scale for Upper Extremity in Stroke Patients (MESUPES). Higher scores indicate better upper extremity motor performance and functional ability.
Baseline and 6 weeks (end of intervention)
Upper Extremity Motor Recovery
Délai: Baseline and 6 weeks (end of intervention)
Motor recovery will be evaluated using the Fugl-Meyer Assessment for Upper Extremity (FMA-UE). The scale assesses motor impairment, coordination, reflex activity, and voluntary movement, with higher scores indicating improved motor recovery.
Baseline and 6 weeks (end of intervention)

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Health-Related Quality of Life
Délai: Baseline and 6 weeks (end of intervention)
Health-related quality of life will be measured using the Short Form-36 Health Survey (SF-36). The questionnaire evaluates physical and mental health domains, with higher scores representing better perceived health status and quality of life.
Baseline and 6 weeks (end of intervention)

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

3 février 2025

Achèvement primaire (Réel)

19 mars 2026

Achèvement de l'étude (Réel)

28 avril 2026

Dates d'inscription aux études

Première soumission

6 juin 2026

Première soumission répondant aux critères de contrôle qualité

6 juin 2026

Première publication (Réel)

11 juin 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

11 juin 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

6 juin 2026

Dernière vérification

1 juin 2026

Plus d'information

Termes liés à cette étude

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner